NanoViricides
NNVC
#10132
Rank
โ‚น1.98 B
Marketcap
โ‚น110.50
Share price
0.82%
Change (1 day)
-10.63%
Change (1 year)

NanoViricides (NNVC) - Total assets

Total assets on the balance sheet as of June 2025 : โ‚น0.79 Billion

According to NanoViricides's latest financial reports the company's total assets are โ‚น0.79 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

NanoViricides - Total assets on balance sheet (from 2006 to 2025)

Total assets by year

Year Total assets Change
2024-06-30โ‚น1.06 B-22.92%
2023-06-30โ‚น1.38 B-25.25%
2022-06-30โ‚น1.85 B-17.57%
2021-06-30โ‚น2.25 B24.24%
2020-06-30โ‚น1.81 B95.39%
2019-06-30โ‚น0.92 B-26.96%
2018-06-30โ‚น1.26 B-27.25%
2017-06-30โ‚น1.74 B-29.44%
2016-06-30โ‚น2.47 B-12%
2015-06-30โ‚น2.80 B6.83%
2014-06-30โ‚น2.63 B169.31%
2013-06-30โ‚น0.97 B12.57%
2012-06-30โ‚น0.86 B80.86%
2011-06-30โ‚น0.47 B14.95%
2010-06-30โ‚น0.41 B190.59%
2009-06-30โ‚น0.14 B127.9%
2008-06-30โ‚น63.01 M15.15%
2007-06-30โ‚น54.72 M-56.73%
2006-06-30โ‚น0.12 B
2005-06-30N/A

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
BioCryst Pharmaceuticals
BCRX
โ‚น40.10 B 4,959.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น105.99 B 13,271.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น5.258 T 663,232.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น8.704 T 1,097,906.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น11.637 T 1,467,996.39%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น7.407 T 934,392.89%๐Ÿ‡ฌ๐Ÿ‡ง UK